Summary

Amends the

to implement the Pharmaceutical Benefits Scheme (PBS) Access and Sustainability package by: applying a one-off five per cent statutory price reduction for single brand medicines; changing price disclosure arrangements for multiple-brand medicines; applying flow-on price disclosure reductions from component drugs to multiple-brand combination medicines; changing membership arrangements for the Pharmaceutical Benefits Advisory Committee; enabling approved pharmacists to discount patient co-payments by a maximum of $1 for each PBS supply on a prescription; extending safety net early supply rules; and extending the pharmacy location rules and the role of the Australian Community Pharmacy Authority to 30 June 2020. Also makes technical amendments.